Insider · CIK 0001967910
Umstead John W. V
Reports to the SEC for 1 company · RESEARCH TRIANGLE PARK, NC
Transactions
18
Companies
1
Filings
9
CIK
0001967910
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2024-09-18 | G1 Therapeutics, Inc.D Disposition to Issuer | — |
| 2024-09-18 | G1 Therapeutics, Inc.U Disposition from Tender | — |
| 2024-09-18 | G1 Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2024-09-18 | G1 Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2024-09-18 | G1 Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2024-07-05 | G1 Therapeutics, Inc.S Sale | −$1,321.558 |
| 2024-07-01 | G1 Therapeutics, Inc.A Award | — |
| 2024-05-13 | G1 Therapeutics, Inc.S Sale | −$39K |
| 2024-03-20 | G1 Therapeutics, Inc.A Award | — |
| 2024-03-18 | G1 Therapeutics, Inc.S Sale | −$19.8K |
| 2024-01-04 | G1 Therapeutics, Inc.S Sale | −$326.595 |
| 2024-01-03 | G1 Therapeutics, Inc.A Award | — |
| 2024-01-03 | G1 Therapeutics, Inc.S Sale | −$789.082 |
| 2024-01-03 | G1 Therapeutics, Inc.S Sale | −$1,182.063 |
| 2024-01-03 | G1 Therapeutics, Inc.Stock Options (Right to Buy)A Award | — |
| 2023-05-10 | G1 Therapeutics, Inc.A Award | — |
| 2023-03-15 | G1 Therapeutics, Inc.A Award | — |
| 2023-03-15 | G1 Therapeutics, Inc.Stock Options (Right to Buy)A Award | — |
Recent filings
- 4Umstead John W. V0000950170-24-107791SEC(opens sec.gov)
- 4Umstead John W. V0001562180-24-005656SEC(opens sec.gov)
- 4Umstead John W. V0001562180-24-005604SEC(opens sec.gov)
- 4Umstead John W. V0001562180-24-004063SEC(opens sec.gov)
- 4Umstead John W. V0001562180-24-002948SEC(opens sec.gov)
- 4Umstead John W. V0001562180-24-002880SEC(opens sec.gov)
- 4Umstead John W. V0001562180-24-000328SEC(opens sec.gov)
- 4Umstead John V.0001562180-23-004096SEC(opens sec.gov)
- 4Umstead John V.0001562180-23-002913SEC(opens sec.gov)
Companies
Address
700 PARK OFFICES DRIVE, SUITE 200
RESEARCH TRIANGLE PARK, NC, 27709